Myeloma
City of Hope
Practical Perspectives on Recent CAR-T FDA Approvals in Myeloma
FEATURING
Murali Janakiram
- 288 views
- April 26, 2024
- 3
ASH 2022 Conference Coverage
ASH 2022 Understanding and Monitoring Resistance to Anti-CD38 and -BCMA Therapies
FEATURING
Flavia Pichiorri
- 203 views
- January 4, 2023
City of Hope
ASCO 2021 Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in R/R MM
FEATURING
Amrita Krishnan
- 124 views
- June 28, 2021
City of Hope
The Promise of Immunotherapy and Newer Agents in Multiple Myeloma
FEATURING
Amrita Krishnan
- 495 views
- October 13, 2017
- 1
City of Hope
Should Everyone Receive Monoclonal Antibodies at First Myeloma Relapse? No!
FEATURING
Joseph Mikhael
- 490 views
- September 8, 2018
- 2